Keystone Symposia: Evolving Approaches to Early-Stage Drug Discovery

Aurigene to participate in Keystone Symposia: Evolving Approaches to Early-Stage Drug Discovery in Utah, USA Conference Link : https://www.keystonesymposia.org/meetings/viewPastMeetings.cfm?MeetingID=1093&CFID=3977659&CFTOKEN=42645832

47th ASCO Annual Meeting

Aurigene tp participate in 47th ASCO Annual Meeting in Chicago, Illinois. Conference Link : https://chicago2011.asco.org/

10th World Congress on Inflammation

Aurigene to participate in 10th World Congress on Inflammation in Paris. Conference Link : https://www.inflammation2011.com/

ACA: Autoimmunity Congress Asia

Aurigene to participate in ACA: Autoimmunity Congress Asia in Singapore. Conference link : https://www2.kenes.com/aca/pages/home.aspx

Agreement with Debiopharm on Immuno oncology targets

DEBIOPHARM AND AURIGENE ENTER INTO AGREEMENT TO IDENTIFY AND DEVELOP SELECTIVE COMPOUNDS FOR IMMUNO-ONCOLOGY TARGETS Lausanne, Switzerland, and Bangalore, India, June 27, 2006 “ The Debiopharm Group (Debiopharm), a global

Discovery Collaborations with Forest Labs on Obesity targets

AURIGENE AND FOREST LABORATORIES TO COLLABORATE ON DEVELOPMENT OF NOVEL ORAL THERAPEUTICS FOR OBESITY AND METABOLIC DISORDERS BANGALORE, India and NEW YORK, February 2nd, 2007– Aurigene Discovery Technologies, Ltd (Aurigene),